These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 21792481)

  • 1. Bilateral pathologic hip fractures associated with antiretroviral therapy: a case report.
    Rebolledo BJ; Unnanuntana A; Lane JM
    J Bone Joint Surg Am; 2011 Jul; 93(14):e78. PubMed ID: 21792481
    [No Abstract]   [Full Text] [Related]  

  • 2. Tenofovir-induced renal tubular dysfunction presenting with hypocalcaemia.
    Williams J; Chadwick DR
    J Infect; 2006 Apr; 52(4):e107-8. PubMed ID: 16125779
    [No Abstract]   [Full Text] [Related]  

  • 3. Bone pain due to fractures revealing osteomalacia related to tenofovir-induced proximal renal tubular dysfunction in a human immunodeficiency virus-infected patient.
    Perrot S; Aslangul E; Szwebel T; Caillat-Vigneron N; Le Jeunne C
    J Clin Rheumatol; 2009 Mar; 15(2):72-4. PubMed ID: 19265350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An unrecognised case of tenofovir-associated Fanconi syndrome.
    Gracey DM; Fernando M; Ziegler J; White CP; Post JJ
    Med J Aust; 2012 Feb; 196():111-2. PubMed ID: 22304601
    [No Abstract]   [Full Text] [Related]  

  • 5. Bone disease and pathologic fractures in a patient with tenofovir-induced Fanconi syndrome.
    Brim NM; Cu-Uvin S; Hu SL; O'Bell JW
    AIDS Read; 2007 Jun; 17(6):322-8, C3. PubMed ID: 17632940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Two cases of Fanconi's syndrome induced by tenofovir in the Ivory Coast].
    Ondounda M; Tanon A; Ehui E; Ouattara I; Kassi A; Aba YT; Aoussi EF; Kakou AR; Eholié SP; Bissagnene E; Kadio A
    Med Mal Infect; 2011 Feb; 41(2):105-7. PubMed ID: 20832214
    [No Abstract]   [Full Text] [Related]  

  • 7. [Role of bone gammagraphy in the diagnosis of secondary osteomalacia in a patient treated with tenofovir].
    Torres Isidro MV; García Benayas T; del Val Gómez Martínez M; González Gallardo F; Gambí Pisonero N; Castilla Miguel S; González-Lahoz J; Gallego Sanz D
    Rev Esp Med Nucl; 2006; 25(2):103-6. PubMed ID: 16759616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of proximal renal tubular dysfunction in patients on tenofovir disoproxil fumarate.
    Quinn KJ; Emerson CR; Dinsmore WW; Donnelly CM
    Int J STD AIDS; 2010 Feb; 21(2):150-1. PubMed ID: 20090006
    [No Abstract]   [Full Text] [Related]  

  • 9. Acute renal failure and Fanconi syndrome in an AIDS patient on tenofovir treatment--case report and review of literature.
    Malik A; Abraham P; Malik N
    J Infect; 2005 Aug; 51(2):E61-5. PubMed ID: 16038754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tenofovir-induced Fanconi syndrome and osteomalacia in two HIV-infected patients: role of intracellular tenofovir diphosphate levels and review of the literature.
    Haverkort ME; van der Spek BW; Lips P; Slieker WA; ter Heine R; Huitema AD; Bronsveld W
    Scand J Infect Dis; 2011 Oct; 43(10):821-6. PubMed ID: 21563880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proximal tubular dysfunction associated with tenofovir and didanosine causing Fanconi syndrome and diabetes insipidus: a report of 3 cases.
    Irizarry-Alvarado JM; Dwyer JP; Brumble LM; Alvarez S; Mendez JC
    AIDS Read; 2009 Mar; 19(3):114-21. PubMed ID: 19334328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toward a pharmacogenetic understanding of nucleotide and nucleoside analogue toxicity.
    Hulgan T; Haas DW
    J Infect Dis; 2006 Dec; 194(11):1471-4. PubMed ID: 17083029
    [No Abstract]   [Full Text] [Related]  

  • 13. Editorial comment: tenofovir nephrotoxicity--the disconnect between clinical trials and real-world practice.
    Atta MG; Fine DM
    AIDS Read; 2009 Mar; 19(3):118-9. PubMed ID: 19334329
    [No Abstract]   [Full Text] [Related]  

  • 14. Osteoporotic fracture risk associated with cumulative exposure to tenofovir and other antiretroviral agents.
    Bedimo R; Maalouf NM; Zhang S; Drechsler H; Tebas P
    AIDS; 2012 Apr; 26(7):825-31. PubMed ID: 22301411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tubulopathy consecutive to tenofovir-containing antiretroviral therapy in two patients infected with human immunodeficiency virus-1.
    Breton G; Alexandre M; Duval X; Prie D; Peytavin G; Leport C; Vildei JL
    Scand J Infect Dis; 2004; 36(6-7):527-8. PubMed ID: 15307594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Tenofovir hypersensitivity to tenofovir (DRESS) syndrome in a female patient infected by HIV].
    Bayonne Kombo ES; Gathse A
    Med Mal Infect; 2013 Mar; 43(3):134-5. PubMed ID: 23434355
    [No Abstract]   [Full Text] [Related]  

  • 17. The development of hypophosphataemic osteomalacia with myopathy in two patients with HIV infection receiving tenofovir therapy.
    Parsonage MJ; Wilkins EG; Snowden N; Issa BG; Savage MW
    HIV Med; 2005 Sep; 6(5):341-6. PubMed ID: 16156882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tenofovir-related nephrotoxicity: case report and review of the literature.
    James CW; Steinhaus MC; Szabo S; Dressier RM
    Pharmacotherapy; 2004 Mar; 24(3):415-8. PubMed ID: 15040657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tenofovir-associated Fanconi syndrome in patients with chronic hepatitis B monoinfection.
    Gracey DM; Snelling P; McKenzie P; Strasser SI
    Antivir Ther; 2013; 18(7):945-8. PubMed ID: 23839869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fanconi syndrome associated with use of tenofovir in HIV-infected patients: a case report and review of the literature.
    Quimby D; Brito MO
    AIDS Read; 2005 Jul; 15(7):357-64. PubMed ID: 16044577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.